![Robert Gundel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Gundel
Keine laufenden Positionen mehr
Profil
Robert Gundel is the founder of Chatham Consulting Group, Inc. (founded in 2007).
He was the President, CEO & Non-Independent Director of ProMIS Neurosciences, Inc. from 2010 to 2015.
He held the position of Director-Pharmacology at Bayer Corp.
and Vice President-Pharmacology & Preclinical Research at Chiron Corp.
He was also the Chief Scientific Officer at Arius Research, Inc. in 2008 and Vice President-Research & Development at Elusys Therapeutics, Inc. in 2008.
In addition, he served as the Interim Chief Scientific & Technology Officer at Scorpius Holdings, Inc. in 2009 and Vice President-Scientific & Corporate Development at XOMA (US) LLC from 2005 to 2007.
Dr. Gundel holds an MBA from St. Mary's College of California and a doctorate from New York Medical College.
Ehemalige bekannte Positionen von Robert Gundel
| Unternehmen | Position | Ende |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Vorstandsvorsitzender | 29.06.2015 |
| SCORPIUS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2008 |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Corporate Officer/Principal | 01.01.2007 |
Ausbildung von Robert Gundel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Health Technology |
Scorpius Holdings, Inc.
 Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
St. Mary's College of California
 St. Mary's College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
Chatham Consulting Group, Inc.
 Chatham Consulting Group, Inc. Insurance Brokers/ServicesFinance Chatham Consulting Group, Inc. is a private company based in Armonk, NY. The company was founded by Robert Gundel. | Finance |
